Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Wisner Baum Takes on Chlorpyrifos Manufacturers in New Parkinson's Disease Lawsuit


      News provided by

      Wisner Baum

      Nov 09, 2026, 08:16 ET

      Share this article

      Share this article


      Wisner Baum has filed a lawsuit on behalf of a Los Angeles County man who alleges years of chlorpyrifos exposure from neighboring commercial nurseries contributed to his early-onset Parkinson's disease. The complaint names three pesticide companies and three commercial nurseries, alleging that the manufacturers failed to investigate and disclose the neurological risks of chlorpyrifos, and that the nurseries failed to protect nearby residents from exposure.

      LOS ANGELES, Nov. 9, 2026 /PRNewswire/ -- Wisner Baum LLP has filed a lawsuit in Los Angeles County Superior Court against The Dow Chemical Company and Corteva, alleging the companies manufactured and sold the pesticide chlorpyrifos while failing to adequately study and disclose its link to Parkinson's disease. The firm represents a Los Angeles County man who was diagnosed with early-onset Parkinson's disease after years of living next to commercial nurseries that allegedly sprayed chlorpyrifos.

      Continue Reading
      “Chlorpyrifos manufacturers had decades to study what this chemical does to the human nervous system. This lawsuit seeks to hold them accountable for what they knew and what they chose not to tell the public.” - Sasha Shariati, Wisner Baum attorney
      “Chlorpyrifos manufacturers had decades to study what this chemical does to the human nervous system. This lawsuit seeks to hold them accountable for what they knew and what they chose not to tell the public.” - Sasha Shariati, Wisner Baum attorney

      The complaint names pesticide companies Corteva, Inc., Corteva Agriscience LLC, and The Dow Chemical Company, which it alleges designed, manufactured, marketed, sold or distributed chlorpyrifos products. According to the complaint, Dow developed chlorpyrifos in the 1950s, and Dow and its affiliated businesses became major manufacturers and sellers of the pesticide in the United States. Corteva announced in February 2020 that it would phase out production of its chlorpyrifos products. The complaint also names three commercial nurseries alleged to have applied chlorpyrifos near the plaintiff's residences: Abeja Nursery, Azul & Verde Nursery, and ABC Nursery, Inc.

      "Chlorpyrifos manufacturers had decades to study what this chemical does to the human nervous system," said Sasha Shariati, a Wisner Baum attorney representing the plaintiff. "This lawsuit seeks to hold them accountable for what they knew and what they chose not to tell the public."

      Alleged Failure to Warn and Take Precautions

      According to the complaint, chlorpyrifos is an organophosphate insecticide that can affect the nervous system. The lawsuit alleges the pesticide companies failed to adequately test for long-term neurological effects, disclose relevant health information, or communicate risks through advertising, training, sales, and other channels outside EPA-approved product labels. It further claims chlorpyrifos was defectively designed and the companies failed to adopt feasible safer designs or formulations.

      The complaint also alleges the nursery defendants failed to take reasonable steps to limit pesticide drift and other off-site exposure, maintain adequate buffers and application controls, or notify nearby residents about applications.

      The complaint cites scientific and epidemiological research that it says supports a relationship between chlorpyrifos exposure and Parkinson's disease, and alleges that safer pesticide alternatives were available during the period of exposure.

      "People living near pesticide applications should not have to guess what is being sprayed or whether it could affect their health," said Shariati. "This case will examine what the defendants knew, how they communicated about chlorpyrifos, and whether reasonable precautions could have reduced exposure to nearby residents."

      Years of Alleged Drift Exposure

      The complaint alleges that the plaintiff was exposed to chlorpyrifos from approximately 2003 to 2020 while living near commercial nursery operations in Los Angeles County. From 2003 to 2013, his residence was about 20 feet from one nursery, with no barrier between the properties. From 2017 to 2022, his backyard fence directly bordered another nursery.

      The lawsuit brings claims under California law for negligent failure to warn, negligent design and strict liability design defect against the pesticide companies, general negligence against all defendants, and trespass against the nurseries. It seeks compensatory and punitive damages.

      Chlorpyrifos Under Global Scrutiny

      California moved to end nearly all sales and use of chlorpyrifos by 2020. The European Union has withdrawn its approval of the pesticide, and a global elimination listing under the Stockholm Convention is scheduled to take effect in December 2026.

      Wisner Baum's Pesticide Litigation Experience

      Wisner Baum has spent years holding chemical manufacturers accountable for the health effects of their products. Firm partner R. Brent Wisner served as co-lead trial counsel in Johnson v. Monsanto, the first Roundup cancer case to go to trial, which resulted in a landmark jury verdict.

      The firm is evaluating claims from people diagnosed with Parkinson's disease after exposure or possible exposure to chlorpyrifos.

      About Wisner Baum

      Wisner Baum is a plaintiffs' law firm representing individuals harmed by corporate misconduct, dangerous products, and environmental exposure. For more information, visit www.wisnerbaum.com.

      References

      • Michael Sargent v. Corteva, Inc., et al., Los Angeles County Superior Court, Case No. 26STCV34705
      • Hasan, K. M. M., Barnhill, L. M., Paul, K. C., Peng, C., Zeiger, W., Ritz, B., Arellano, M., Ajnassian, M., Zhang, S., Theint, A. T., Elezi, G., Weinberger, H., Whitelegge, J. P., Bai, Q., Li, S., Burton, E. A., & Bronstein, J. M. (2025). The pesticide chlorpyrifos increases the risk of Parkinson's disease. Molecular Neurodegeneration, 21, Article 3.

      Media Contact

      Karla Jo Helms
      JoTo PR Disruptors
      727-777-4629
      www.jotopr.com

      SOURCE Wisner Baum

      Modal title

      Also from this source

      Wisner Baum Lawsuit Alleges Syngenta Failed to Warn of Atrazine's Cancer Risks

      Wisner Baum Lawsuit Alleges Syngenta Failed to Warn of Atrazine's Cancer Risks

      Nationally recognized plaintiffs' firm Wisner Baum LLP has filed a lawsuit against Syngenta on behalf of California resident Apostolos Panayiotou,...

      Breast Cancer Awareness Month Raises Questions About Antipsychotic Drug Warnings

      Breast Cancer Awareness Month Raises Questions About Antipsychotic Drug Warnings

      As Breast Cancer Awareness Month places prevention, screening and early detection in the national spotlight, Wisner Baum LLP attorney and partner...

      More Releases From This Source

      Explore

      Hispanic

      Hispanic

      News Releases in Similar Topics

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.